Beyond PD-1/PD-L1: TME-Targeted Therapies in the Era of Immunotherapy Resistance. J Biomol Pathog Ther [Internet]. 2026 Mar. 10 [cited 2026 Jun. 2];2(1):1-3. Available from: https://jbptjournal.org/index.php/jbpt/article/view/33